Tilray Brands Debt to Equity Ratio 2017-2025 | TLRY
Current and historical debt to equity ratio values for Tilray Brands (TLRY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Tilray Brands debt/equity for the three months ending February 28, 2025 was 0.12.
| Tilray Brands Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-02-28 | $0.70B | $2.70B | 0.26 |
| 2024-11-30 | $0.74B | $3.45B | 0.21 |
| 2024-08-31 | $0.78B | $3.48B | 0.22 |
| 2024-05-31 | $0.78B | $3.44B | 0.23 |
| 2024-02-29 | $0.87B | $3.34B | 0.26 |
| 2023-11-30 | $0.94B | $3.39B | 0.28 |
| 2023-08-31 | $1.00B | $3.40B | 0.29 |
| 2023-05-31 | $0.98B | $3.33B | 0.29 |
| 2023-02-28 | $0.97B | $3.41B | 0.28 |
| 2022-11-30 | $0.99B | $4.48B | 0.22 |
| 2022-08-31 | $1.03B | $4.56B | 0.23 |
| 2022-05-31 | $1.01B | $4.44B | 0.23 |
| 2022-02-28 | $1.16B | $4.66B | 0.25 |
| 2021-11-30 | $1.29B | $4.47B | 0.29 |
| 2021-08-31 | $1.60B | $4.39B | 0.37 |
| 2021-05-31 | $1.56B | $4.47B | 0.35 |
| 2021-03-31 | $0.63B | $0.54B | 1.16 |
| 2021-02-28 | $0.00B | 0.00 | |
| 2020-12-31 | $0.00B | 0.00 | |
| 2020-11-30 | $0.00B | 0.00 | |
| 2020-09-30 | $0.70B | $0.19B | 3.75 |
| 2020-08-31 | $0.00B | 0.00 | |
| 2020-06-30 | $0.72B | $0.13B | 5.51 |
| 2020-03-31 | $0.73B | $0.19B | 3.81 |
| 2019-12-31 | $0.00B | 0.00 | |
| 2019-09-30 | $0.62B | $0.42B | 1.50 |
| 2019-06-30 | $0.66B | $0.36B | 1.84 |
| 2019-03-31 | $0.70B | $0.38B | 1.82 |
| 2018-12-31 | $0.46B | $0.20B | 2.32 |
| 2018-09-30 | $0.04B | $0.19B | 0.19 |
| 2018-06-30 | $0.07B | $0.04B | 2.02 |
| 2018-03-31 | $0.06B | $0.04B | 1.50 |
| 2018-02-28 | $0.00B | $0.00B | 0.00 |
| 2017-12-31 | $0.06B | $-0.01B | -12.12 |
| 2017-11-30 | $0.06B | $-0.01B | -12.12 |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-08-31 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
| 2017-05-31 | $0.00B | $0.00B | 0.00 |
| 2017-03-31 | $0.00B | 0.00 | |
| 2017-02-28 | $0.03B | $0.00B | 12.09 |
| 2016-11-30 | $0.03B | $0.00B | 12.09 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.436B | $0.789B |
| Tilray Brands Inc. is a cannabis-lifestyle and consumer packaged goods company. It operates principally in Canada, the United States, Europe, Australia and Latin America. Tilray Brands Inc., formerly known as Tilray Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.485B | 27.83 |
| Boston Scientific (BSX) | United States | $154.809B | 38.76 |
| Stryker (SYK) | United States | $144.946B | 30.31 |
| EssilorLuxottica (ESLOY) | France | $134.105B | 0.00 |
| Medtronic (MDT) | Ireland | $108.260B | 15.35 |
| Haleon (HLN) | United Kingdom | $50.025B | 28.46 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.059B | 0.00 |
| ResMed (RMD) | United States | $36.038B | 27.07 |
| GE HealthCare Technologies (GEHC) | United States | $31.860B | 15.13 |
| Agilent Technologies (A) | United States | $31.051B | 20.51 |
| Terumo (TRUMY) | Japan | $27.450B | 35.65 |
| Insulet (PODD) | United States | $22.837B | 89.64 |
| Koninklijke Philips (PHG) | Netherlands | $22.023B | 15.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.348B | 11.78 |
| Baxter (BAX) | United States | $15.616B | 11.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.578B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.204B | 21.59 |
| Lantheus Holdings (LNTH) | United States | $5.198B | 13.11 |
| Prestige Consumer Healthcare (PBH) | United States | $4.172B | 18.64 |
| Perrigo (PRGO) | Ireland | $3.700B | 9.38 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.362B | 14.64 |
| ICU Medical (ICUI) | United States | $3.218B | 23.73 |
| Envista Holdings (NVST) | United States | $2.820B | 23.44 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| QuidelOrtho (QDEL) | United States | $2.000B | 13.76 |
| LeMaitre Vascular (LMAT) | United States | $1.841B | 41.16 |
| AtriCure (ATRC) | United States | $1.647B | 0.00 |
| Neogen (NEOG) | United States | $1.350B | 17.28 |
| Acuren (TIC) | United States | $1.305B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.223B | 12.41 |
| Kestra Medical Technologies (KMTS) | United States | $1.186B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.169B | 26.29 |
| BioLife Solutions (BLFS) | United States | $1.049B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.05 |
| InMode (INMD) | Israel | $0.898B | 9.05 |
| CeriBell (CBLL) | United States | $0.634B | 0.00 |
| Evolus (EOLS) | United States | $0.618B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.554B | 0.00 |
| Owens & Minor (OMI) | United States | $0.531B | 4.40 |
| Valneva SE (VALN) | France | $0.527B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.508B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.338B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.315B | 11.58 |
| Aurora Cannabis (ACB) | Canada | $0.293B | 52.20 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.267B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Verano Holdings (VRNOF) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.237B | 10.78 |
| Biote (BTMD) | United States | $0.212B | 5.95 |
| Brainsway (BWAY) | Israel | $0.196B | 52.00 |
| OraSure Technologies (OSUR) | United States | $0.190B | 0.00 |
| Quanterix (QTRX) | United States | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Omeros (OMER) | United States | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.176B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.173B | 14.11 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.07 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Fonar (FONR) | United States | $0.085B | 10.96 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| United Health Products (UEEC) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.44 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 32.29 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |